24 May 2013
Keywords: exelixis, appoints, frances, heller, executive, vp, biotechnology
Article | 28 July 2008
US biotechnology firm Exelixis has appointed Frances Heller as executive vice president of business development. Ms Heller joins the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 July 2008
21 July 2008
© 2013 thepharmaletter.com